1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Casey Cosgrove: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma Biospecimen Collection, Computed Tomography, Dostarlimab - Recurrent Endometrial Serous Adenocarcinoma | Phase 2 | Active not recruiting | Casey Cosgrove | 8 | 2023-10-17 | 2026-03-27 |
Disulfides (1) · Immunoglobulin G (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · dostarlimab (1) · niraparib (1)
United States (1)